Amgen (AMGN) Tops Q1 EPS by 15c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Alaska LNG shipping savings justifies billions in investment, developer says
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
Amgen Reports First Quarter 2017 Financial Results
April 26, 2017 4:05 PM EDTTHOUSAND OAKS, Calif., April 26, 2017 /PRNewswire/ --Â Amgen (NASDAQ: AMGN) today announced financial results for the first quarter of 2017. Key results include:
Total revenues decreased 1 percent versus the first quarter of 2016 to $5.5 billion. GAAP earnings per share (EPS) increased 12 percent to $2.79 driven by higher operating margins. GAAP operating income increased 8 percent to $2.6 billion and GAAP operating margin increased 4 percentage points to 49.8 percent. Non-GAAP EPS increased 9 percent to $3.15 driven by higher operating margins. Non-GAAP operating income increased 5 percent to $3.0... More


